Abstract 12743: The Role of Combined Treatment With Ascorbic Acid and N-Acetylcysteine in Prevention of Contrast-Induced Nephropathy in High-Risk Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Artigo Revisado por pares

Abstract 12743: The Role of Combined Treatment With Ascorbic Acid and N-Acetylcysteine in Prevention of Contrast-Induced Nephropathy in High-Risk Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

2010; Lippincott Williams & Wilkins; Volume: 122; Linguagem: Inglês

ISSN

1524-4539

Autores

Marek Grygier, Magda Janus, Aleksander Araszkiewicz, Jadwiga Kowal, Tatiana Mularek‐Kubzdela, Wojciech Seniuk, Anna Olasińska‐Wiśniewska, Małgorzata Popiel, Maciej Lesiak, Stefan Grajek,

Tópico(s)

Folate and B Vitamins Research

Resumo

Background: Patients with acute myocardial infarction undergoing percutaneous coronary intervention (PCI) are at high-risk of contrast-induced nephropathy. Conflicting evidence suggests that admini...

Ver no editor

Entrar

Lembrar minha senha

Receber meu e-mail de confirmação

Abstract 12743: The Role of Combined Treatment With Ascorbic Acid and N-Acetylcysteine in Prevention of Contrast-Induced Nephropathy in High-Risk Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.